98 related articles for article (PubMed ID: 17560008)
1. Modulation of T-effector function by imatinib at the level of cytokine secretion.
Leder C; Ortler S; Seggewiss R; Einsele H; Wiendl H
Exp Hematol; 2007 Aug; 35(8):1266-71. PubMed ID: 17560008
[TBL] [Abstract][Full Text] [Related]
2. The receptor for hyaluronic acid-mediated motility induces specific CD8+ T cell response in healthy donors and patients with chronic myeloid leukemia after allogeneic stem cell transplantation.
Chen J; Schmitt A; Bunjes D; Chen B; Schmitt M
Int J Oncol; 2007 May; 30(5):1119-27. PubMed ID: 17390013
[TBL] [Abstract][Full Text] [Related]
3. Imatinib impairs the proliferation and function of CD4+CD25+ regulatory T cells in a dose-dependent manner.
Chen J; Schmitt A; Giannopoulos K; Chen B; Rojewski M; Döhner H; Bunjes D; Schmitt M
Int J Oncol; 2007 Nov; 31(5):1133-9. PubMed ID: 17912440
[TBL] [Abstract][Full Text] [Related]
4. Redox modulation inhibits CD8 T cell effector function.
Sklavos MM; Tse HM; Piganelli JD
Free Radic Biol Med; 2008 Nov; 45(10):1477-86. PubMed ID: 18805480
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of bystander recruitment and cytotoxic functions of the IFN-gamma producing alloreactive CD8+ T cells in mice.
Köksoy S; Mathes LE
Immunol Lett; 2005 Feb; 97(1):141-9. PubMed ID: 15626486
[TBL] [Abstract][Full Text] [Related]
6. Effects of imatinib on normal hematopoiesis and immune activation.
Appel S; Balabanov S; Brümmendorf TH; Brossart P
Stem Cells; 2005 Sep; 23(8):1082-8. PubMed ID: 16140870
[TBL] [Abstract][Full Text] [Related]
7. Type 1 CD8+ T cells are superior to type 2 CD8+ T cells in tumor immunotherapy due to their efficient cytotoxicity, prolonged survival and type 1 immune modulation.
Ye Z; Tang C; Xu S; Zhang B; Zhang X; Moyana T; Yang J; Xiang J
Cell Mol Immunol; 2007 Aug; 4(4):277-85. PubMed ID: 17764618
[TBL] [Abstract][Full Text] [Related]
8. Intracellular CD154 expression reflects antigen-specific CD8+ t cells but shows less sensitivity than intracellular cytokine and MHC tetramer staining.
Han YW; Aleyas AG; George JA; Yoon HA; Lee JH; Kim BS; Eo SK
J Microbiol Biotechnol; 2007 Dec; 17(12):1955-64. PubMed ID: 18167442
[TBL] [Abstract][Full Text] [Related]
9. Suppression of choroidal neovascularization by dendritic cell vaccination targeting VEGFR2.
Mochimaru H; Nagai N; Hasegawa G; Kudo-Saito C; Yaguchi T; Usui Y; Kurihara T; Koto T; Satofuka S; Shinoda H; Ozawa Y; Tsubota K; Kawakami Y; Ishida S
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4795-801. PubMed ID: 17898306
[TBL] [Abstract][Full Text] [Related]
10. B7-H1 on hepatocytes facilitates priming of specific CD8 T cells but limits the specific recall of primed responses.
Wahl C; Bochtler P; Chen L; Schirmbeck R; Reimann J
Gastroenterology; 2008 Sep; 135(3):980-8. PubMed ID: 18621049
[TBL] [Abstract][Full Text] [Related]
11. Suppression of alkali burn-induced corneal neovascularization by dendritic cell vaccination targeting VEGF receptor 2.
Mochimaru H; Usui T; Yaguchi T; Nagahama Y; Hasegawa G; Usui Y; Shimmura S; Tsubota K; Amano S; Kawakami Y; Ishida S
Invest Ophthalmol Vis Sci; 2008 May; 49(5):2172-7. PubMed ID: 18263815
[TBL] [Abstract][Full Text] [Related]
12. Effect of phosphodiesterase 7 inhibitor ASB16165 on development and function of cytotoxic T lymphocyte.
Kadoshima-Yamaoka K; Murakawa M; Goto M; Tanaka Y; Inoue H; Murafuji H; Hayashi Y; Nagahira K; Miura K; Nakatsuka T; Chamoto K; Fukuda Y; Nishimura T
Int Immunopharmacol; 2009 Jan; 9(1):97-102. PubMed ID: 18992850
[TBL] [Abstract][Full Text] [Related]
13. Ag-specific type 1 CD8 effector cells enhance methotrexate-mediated antitumor responses by modulating endogenous CD49b-expressing CD4 and CD8 T effector cell subpopulations producing IL-10.
Dobrzanski MJ; Reome JB; Hylind JC; Rewers-Felkins KA; Abdulsamad K; Adams SL
Immunol Invest; 2008; 37(4):315-38. PubMed ID: 18569073
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes.
Zimmermann M; Flechsig C; La Monica N; Tripodi M; Adler G; Dikopoulos N
J Hepatol; 2008 Jan; 48(1):51-60. PubMed ID: 17998148
[TBL] [Abstract][Full Text] [Related]
15. Characterization of migratory activity and cytokine profile of helper and cytotoxic CMV-specific T-cell lines expanded by a selective peptide library.
Dander E; Li Pira G; Biagi E; Perseghin P; Renoldi G; Gaipa G; Introna M; Marin V; Manca F; Biondi A; D'Amico G
Exp Hematol; 2008 Apr; 36(4):473-85. PubMed ID: 18261836
[TBL] [Abstract][Full Text] [Related]
16. A Th17-like developmental process leads to CD8(+) Tc17 cells with reduced cytotoxic activity.
Huber M; Heink S; Grothe H; Guralnik A; Reinhard K; Elflein K; Hünig T; Mittrücker HW; Brüstle A; Kamradt T; Lohoff M
Eur J Immunol; 2009 Jul; 39(7):1716-25. PubMed ID: 19544308
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of interferon-gamma and interleukin-4, Th cell-derived cytokines by So-Shi-Ho-Tang (Sho-Saiko-To) occurs at the level of antigen presenting cells, but not CD4 T cells.
Kang H; Choi TW; Ahn KS; Lee JY; Ham IH; Choi HY; Shim ES; Sohn NW
J Ethnopharmacol; 2009 May; 123(1):6-14. PubMed ID: 19429332
[TBL] [Abstract][Full Text] [Related]
18. Antigen-primed splenic CD8+ T cells impede the development of oral antigen-induced allergic diarrhea.
Yamada A; Ohshima Y; Yasutomi M; Ogura K; Tokuriki S; Naiki H; Mayumi M
J Allergy Clin Immunol; 2009 Apr; 123(4):889-94. PubMed ID: 19201014
[TBL] [Abstract][Full Text] [Related]
19. Ethanol consumption modifies dendritic cell antigen presentation in mice.
Heinz R; Waltenbaugh C
Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
[TBL] [Abstract][Full Text] [Related]
20. Imatinib inhibits the activation and proliferation of normal T lymphocytes in vitro.
Cwynarski K; Laylor R; Macchiarulo E; Goldman J; Lombardi G; Melo JV; Dazzi F
Leukemia; 2004 Aug; 18(8):1332-9. PubMed ID: 15190258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
